An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma

BACKGROUND: An immune-related gene signature (IGS) was established for discriminating prognosis, predicting benefit of immunotherapy, and exploring therapeutic options in hepatocellular carcinoma (HCC). METHODS: Based on Immune-related hub genes and The Cancer Genome Atlas (TCGA) LIHC dataset (n = 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ninghua, Jiang, Wei, Wang, Yilang, Song, Qianqian, Cao, Xiaolei, Zheng, Wenjie, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015788/
https://www.ncbi.nlm.nih.gov/pubmed/36918943
http://dx.doi.org/10.1186/s40001-023-01091-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015788/
https://www.ncbi.nlm.nih.gov/pubmed/36918943
http://dx.doi.org/10.1186/s40001-023-01091-w

Ejemplares similares